0 Evaluaciones
ID

20388

Descripción

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. End of Trial Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Palabras clave

Versiones (1)
  1. 21/2/17 21/2/17 -
Subido en

21 de febrero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    Inglés

    End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 formularios  
    Concomitant Medication
    Descripción

    Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    1. Since the visit 5, were any of the non-study medications listed below taken?
    Descripción

    Medication taken

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1553892
    If yes, please indicate which of the following were being taken:
    Descripción

    If yes, please indicate which

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C1553892
    ACE Inhibitors
    Descripción

    ACE Inhibitors

    Alias
    UMLS CUI-1
    C0003015
    2. Since the visit 5, were any ACE inhibitors taken?
    Descripción

    ACE Inhibitors currently taken

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0013227
    If Yes, please indicate which, and total daily dose:
    Descripción

    Name of ACE Inhibitor and Total Daily Dose

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0003015
    UMLS CUI [1,2]
    C2360065
    UMLS CUI [2,1]
    C0003015
    UMLS CUI [2,2]
    C2348070
    Restricted Concomitant Medication
    Descripción

    Restricted Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    UMLS CUI-2
    C0233470
    3. Have any restricted medications in the categories defined on the opposite page been taken?
    Descripción

    Restricted medication taken

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1518384
    UMLS CUI [1,2]
    C0087111
    If yes, please indicate which category
    Descripción

    if yes

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C0683312
    Volver a la parte superior de la página

    Similar models

    End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Concomitant Medication
    C2347852 (UMLS CUI-1)
    Medication taken
    Item
    1. Since the visit 5, were any of the non-study medications listed below taken?
    boolean
    C1553892 (UMLS CUI [1])
    Item
    If yes, please indicate which of the following were being taken:
    integer
    C1553892 (UMLS CUI [1])
    If yes, please indicate which
    Code List
    If yes, please indicate which of the following were being taken:
    CL Item
    Parental anticoagulants (Short term use) (1)
    CL Item
    Oral anticoagulants (Short term use) (2)
    CL Item
    Nitrates (oral or topical) (3)
    CL Item
    Estrogen replacement without progesterone (4)
    CL Item
    Estrogen replacement with progesterone (5)
    CL Item
    Digitalis (6)
    CL Item
    Statins (7)
    CL Item
    Fibrates (8)
    CL Item
    Dilitazem/Verapamil (9)
    CL Item
    Other calcium channel blockers (10)
    CL Item
    Alpha-blocker (11)
    CL Item
    Direct vasodilators (12)
    CL Item
    Peripheral sympatholytic (13)
    CL Item
    Central sympatholytic (14)
    CL Item
    Alpha-beta blocker (15)
    CL Item
    Beta-blocker (16)
    CL Item
    Loop-active diuretics (17)
    CL Item
    Diuretics of thiazide type (18)
    CL Item
    Potassium-sparing diuretics (19)
    CL Item
    Insulin (20)
    CL Item
    Oral hypoglycemic agents (21)
    CL Item
    Specific Cox II inhibitors (22)
    Item Group
    ACE Inhibitors
    C0003015 (UMLS CUI-1)
    ACE Inhibitors currently taken
    Item
    2. Since the visit 5, were any ACE inhibitors taken?
    boolean
    C0013227 (UMLS CUI [1])
    Name of ACE Inhibitor and Total Daily Dose
    Item
    If Yes, please indicate which, and total daily dose:
    text
    C0003015 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    C0003015 (UMLS CUI [2,1])
    C2348070 (UMLS CUI [2,2])
    Item Group
    Restricted Concomitant Medication
    C2347852 (UMLS CUI-1)
    C0233470 (UMLS CUI-2)
    Restricted medication taken
    Item
    3. Have any restricted medications in the categories defined on the opposite page been taken?
    boolean
    C1518384 (UMLS CUI [1,1])
    C0087111 (UMLS CUI [1,2])
    Item
    If yes, please indicate which category
    integer
    C0683312 (UMLS CUI [1])
    if yes
    Code List
    If yes, please indicate which category
    CL Item
    1 (1)
    CL Item
    2 (2)
    CL Item
    3 (3)
    CL Item
    4 (4)
    CL Item
    5 (5)
    CL Item
    6 (6)
    CL Item
    7 (7)
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial